Amneal Pharmaceuticals
AMRX
AMRX
153 hedge funds and large institutions have $666M invested in Amneal Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more funds holding
Funds holding: 144 → 153 (+9)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30.3% less ownership
Funds ownership: 66.08% → 35.78% (-30%)
Holders
153
Holding in Top 10
1
Calls
$3.58M
Puts
$92K
Top Buyers
| 1 | +$24.1M | |
| 2 | +$23.1M | |
| 3 | +$6.38M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.15M |
| 5 |
BlackRock
New York
|
+$4.94M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$4.72M | |
| 3 | -$3.59M | |
| 4 |
Millennium Management
New York
|
-$3.09M |
| 5 |
JPMorgan Chase & Co
New York
|
-$2.43M |